Article info
PDFReviews
The neurofibromatoses
- Correspondence to Dr RE Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis Service, Guy's and St Thomas' Hospitals NHS Trust, and Honorary Senior Lecturer in Neurology King's College London, Department of Neurology, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK; rosalie.ferner{at}kcl.ac.uk
Citation
The neurofibromatoses
Publication history
- First published March 22, 2010.
Online issue publication
April 14, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Guidelines for the diagnosis and management of individuals with neurofibromatosis 1
- Neurofibromatosis type 1: from genotype to phenotype
- A clinical study of type 1 neurofibromatosis in north west England
- Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions
- Can the diagnosis of NF1 be excluded clinically? A lack of pigmentary findings in families with spinal neurofibromatosis demonstrates a limitation of clinical diagnosis
- Annual review of children with neurofibromatosis type 1
- Ophthalmological manifestations in segmental neurofibromatosis type 1
- Spontaneous pneumothorax as a clinical manifestation of neurofibromatosis type 1
- Evaluation of genotype-phenotype correlations in neurofibromatosis type 1
- Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas